Assessment of cognitive dysfunction, depression, and anxiety in patients with stable chronic obstructive pulmonary disease in relation to serum interleukin-6
Samah M Shehata, Ahmad Abbas, Hala A Fathy and 2 more
Egyptian Journal of Chest Disease and Tuberculosis · 2018
doi:10.4103/ejcdt.ejcdt_68_18 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background Chronic obstructive pulmonary disease (COPD) is a well-recognized multicomponent disease, but its influences on cognitive function and other associated psychological disorders were poorly identified. Systemic inflammation is considered as a key link between these diseases. Aim To assess the cognitive impairment, anxiety, and depression among stable COPD patients using different neuropsychological tests, in relation with serum interleukin-6 (IL-6). Patients and methods A study was conducted upon 100 stable COPD patients and 25 controls. All the participants were subjected to neurological and psychiatric assessment, such as The Generalized Anxiety Disorder-7 scale, Beck Depression Inventory-II scale, and Montreal Cognitive Assessment scale. Serum IL-6 was measured for all participants. Results COPD patients had more frequent anxiety disorders, depression, cognitive dysfunction, and higher serum IL-6 than control group. Visual-spatial/executive and delayed recall domains of cognitive dysfunction were significantly affected in COPD than controls (P<0.001), whereas other domains (Naming, Attention, Language, Abstraction, and Orientation) did not reach a significant level of statistical difference. Generalized Anxiety Disorder-7 anxiety score showed a significant positive correlation with modified medical research council and serum IL-6 and a significant negative correlation with forced expiratory volume in the first second%. Beck Depression Inventory-II score showed a significant positive correlation with BMI. Montreal Cognitive Assessment score showed a significant positive correlation with forced expiratory volume in the first second% and a significant negative correlation with serum IL-6. A cut-off value of serum IL-6 more than 2.6 pg/ml had sensitivity and specificity for prediction of cognitive dysfunction in COPD patients (86.1 and 66.7%, respectively; P<0.001). Conclusion Anxiety, depression, and cognitive impairment were significantly more prevalent between COPD patients. Serum IL-6 was a valid predictor for cognitive dysfunction in COPD patients.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.